TE_17890
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | HAL1ME |
---|---|
TE superfamily | L1 |
TE class | LINE |
Gene | - |
Class | Intergenic |
Coding | Non-coding |
Tumor-specific score | 220.91 |
Counts of samples | TCGA_tumor:195; TCGA_normal:0; GTEx:0 |
TSS | chr8(+):54465952 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_17890.1 | - | Intergenic | Non-coding | Non-coding | chr8(+):54465953,54466035,54466559,54466720,54469388,54469504,54469718,54469738 |
teRNA_17890.2 | - | Intergenic | Non-coding | Non-coding | chr8(+):54465953,54466035,54466559,54469894,54470018,54470038 |
teRNA_17890.3 | - | Intergenic | Non-coding | Non-coding | chr8(+):54465953,54466035,54466559,54466720,54467196,54467216 |
teRNA_17890.4 | - | Intergenic | Non-coding | Non-coding | chr8(+):54465953,54466035,54466559,54466981,54467108,54467128 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.